Downstream processing (DSP) remains one of the most technically demanding and resource-intensive stages in industrial biotechnology. It often determines the economic feasibility and scalability of biomanufacturing processes. As the productivity and complexity of upstream bioprocesses have increased over the past century, separation and purification strategies have had to evolve to meet stricter requirements in product quality, process efficiency, and sustainability. In this article, the evolution of DSP is analyzed in terms of industrial drivers that have historically shaped the development and adoption of separation technologies. A critical assessment of the past hundred years of downstream innovation is presented, identifying six major eras characterized by shifts in dominant priorities, including scalability and robustness, resource efficiency and sustainability, automation and process control, and digitalization and artificial intelligence. These transitions exemplify how technological advances and industrial constraints have jointly directed the progression of purification strategies. To illustrate how these industrial drivers have influenced the design and implementation of downstream strategies across multiple stages of biotechnological development, insulin production is further examined as a representative case study. Finally, the emerging role of data-driven optimization, artificial intelligence, and real-time monitoring in shaping the next generation of DSP platforms is discussed. Rather than offering an exhaustive technical analysis of individual separation operations, this article adopts an integrative, historically grounded perspective that connects industrial drivers with technological transitions over a century of DSP development.
